ASMB (STOCKS)
Assembly Biosciences, Inc
$29.240000
+0.820000 (+2.89%)
Prev close: $28.420000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jason A. Okazaki
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $463.51M
- Employees
- 73
- P/E (TTM)
- -15.46
- P/B (TTM)
- 2.18
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $72.30M |
| Benefits Costs and Expenses | $78.43M |
| Costs And Expenses | $78.43M |
| Nonoperating Income/Loss | $6.00M |
| Operating Expenses | $84.42M |
| Research and Development | $64.81M |
| Other Operating Expenses | $19.61M |
| Operating Income/Loss | -$12.12M |
| Income/Loss From Continuing Operations After Tax | -$6.12M |
| Income/Loss From Continuing Operations Before Tax | -$6.12M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$6.12M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$6.12M |
| Net Income/Loss Available To Common Stockholders, Basic | -$6.12M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.55 |
| Diluted Earnings Per Share | -$0.55 |
| Basic Average Shares | 11,210,934 |
| Diluted Average Shares | 11,210,934 |
| Assets | $257.59M |
| Current Assets | $254.55M |
| Cash | $248.10M |
| Other Current Assets | $6.45M |
| Noncurrent Assets | $3.04M |
| Fixed Assets | $221.00K |
| Other Non-current Assets | $2.82M |
| Liabilities | $50.84M |
| Current Liabilities | $48.78M |
| Accounts Payable | $1.17M |
| Wages | $7.52M |
| Other Current Liabilities | $40.09M |
| Noncurrent Liabilities | $2.06M |
| Equity | $206.75M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $206.75M |
| Liabilities And Equity | $257.59M |
| Net Cash Flow From Operating Activities | -$41.09M |
| Net Cash Flow From Operating Activities, Continuing | -$41.09M |
| Net Cash Flow From Investing Activities | -$113.47M |
| Net Cash Flow From Investing Activities, Continuing | -$113.47M |
| Net Cash Flow From Financing Activities | $174.67M |
| Net Cash Flow From Financing Activities, Continuing | $174.67M |
| Net Cash Flow | $20.11M |
| Net Cash Flow, Continuing | $20.11M |
| Comprehensive Income/Loss | -$5.95M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$5.95M |
| Other Comprehensive Income/Loss | $170.00K |